Nature Communications (Jan 2024)
Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
- Suad Hannawi,
- Linda Saf Eldin,
- Alaa Abuquta,
- Ahmad Alamadi,
- Sally A. Mahmoud,
- Aala Hassan,
- Shuping Xu,
- Jian Li,
- Dongfang Liu,
- Adam Abdul Hakeem Baidoo,
- Dima Ibrahim,
- Mojtaba Alhaj,
- Yuanxin Chen,
- Qiang Zhou,
- Liangzhi Xie
Affiliations
- Suad Hannawi
- Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital
- Linda Saf Eldin
- General Surgery Department, Al Kuwait-Dubai (ALBaraha) Hospital
- Alaa Abuquta
- Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital
- Ahmad Alamadi
- Ear, Nose and Throat Department (ENT), Al Kuwait-Dubai (ALBaraha) Hospital
- Sally A. Mahmoud
- Biogenix labs, G42 Healthcare
- Aala Hassan
- Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital
- Shuping Xu
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Jian Li
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Dongfang Liu
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Adam Abdul Hakeem Baidoo
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Dima Ibrahim
- Infectious Diseases Department, Burjeel Medical City
- Mojtaba Alhaj
- Research Department, Burjeel Medical City
- Yuanxin Chen
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Qiang Zhou
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- Liangzhi Xie
- Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.
- DOI
- https://doi.org/10.1038/s41467-024-44729-x
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 1
Abstract
No abstracts available.